Si Hyun Bae
Overview
Explore the profile of Si Hyun Bae including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
244
Citations
3381
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim J, Park H, Park S, Kim S, Lim J, Lee K, et al.
Clin Mol Hepatol
. 2025 Jan;
PMID: 39838827
Background/aims: Epithelial-to-mesenchymal transition (EMT) plays a crucial role in hepatic fibrogenesis and liver repair in chronic liver disease. Our research highlights the antifibrotic potential of placenta-derived mesenchymal stem cells (PD-MSCs)...
2.
Kim J, Kim H, Tak K, Han J, Nam H, Sung P, et al.
Clin Mol Hepatol
. 2025 Jan;
PMID: 39743888
Background/aims: Hepatocellular carcinoma (HCC) exhibits significant sex disparities in incidence, yet its molecular mechanisms remain unclear. We explored the role of telomerase reverse transcriptase (TERT) genetic alterations and hepatitis B...
3.
Lee J, Han C, Lee D, Sung P, Bae S, Yang H
Gut Liver
. 2024 Dec;
19(1):116-125.
PMID: 39639749
Background/aims: Although numerous noninvasive steatosis indices have been developed to assess hepatic steatosis, whether they can be applied to young adults in the evaluation of metabolic dysfunction-associated steatotic liver disease...
4.
Lee J, So J, Han C, Yang H, Sung P, Bae S, et al.
Hepatol Int
. 2024 Oct;
19(1):181-190.
PMID: 39394385
Background And Aim: Although appendicular skeletal muscle mass (ASM) has been linked to the severity of hepatic steatosis, investigations of its correlation among younger age groups are lacking. We aimed...
5.
Cha J, Park N, Cho S, Nam H, Yang H, Jung E, et al.
Front Immunol
. 2024 Oct;
15:1444100.
PMID: 39381000
Background: Metabolic dysfunction-associated steatohepatitis (MASH) is characterized by persistent inflammatory cascades, with macrophage activation playing a pivotal role. Chitinase 1 (CHIT1), produced by activated macrophages, is a key player in...
6.
Lee S, Kwon J, Jang J, Bae S, Yoon S, Jung E, et al.
Transplantation
. 2024 Oct;
PMID: 39375899
Liver transplantation (LT) is the ultimate treatment for patients with end-stage liver disease or early hepatocellular carcinoma. In the context of LT, because of the unique immunological characteristics of human...
7.
Lee S, Park S, Park S, Lee S, Cho B, Eom K, et al.
Diagnostics (Basel)
. 2024 Aug;
14(16).
PMID: 39202234
Hepatic graft-versus-host disease (GVHD) significantly impacts morbidity and mortality among allogeneic hematopoietic stem cell transplant recipients. However, the relationship between clinical and immunopathological phenotypes and their influence on clinical outcomes...
8.
Yang K, Kim S, Yang H, Wang S, Jeong B, Lim H, et al.
Clin Mol Hepatol
. 2024 Aug;
30(4):929-942.
PMID: 39188230
Background/aims: Alcohol-associated liver disease (ALD) is a public health concern. ALD patients often have psychiatric comorbidities, but the effects of psychiatric interventions on ALD are not well-established. This study explores...
9.
Nam H, Lee J, Han J, Lee S, Yang H, Lee H, et al.
Liver Cancer
. 2024 Aug;
13(4):413-425.
PMID: 39114756
Introduction: Despite the emergence of atezolizumab and bevacizumab (A + B) as standard first-line systemic therapy for unresectable hepatocellular carcinoma (HCC), a comprehensive understanding of the clinical significance of immune-related...
10.
Kim H, Kim J, Kim J, Han J, Lee S, Nam H, et al.
Liver Int
. 2024 Jul;
44(10):2753-2762.
PMID: 39073214
Background And Aims: Molecular processes driving immune-active chronic hepatitis B (CHB) with and without hepatitis B e antigen (HBeAg) remain incompletely understood. This study aimed to investigate expression profiles of...